Aptar today announced their participation at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024.
Stephan Tanda, President and CEO, will present at 1:30 p.m. Eastern Standard Time. Bob Kuhn, Executive Vice President and CFO, and Gael Touya, President Aptar Pharma, will also be available.
A copy of the presentation will be made available on the Investors page at www.aptar.com.
Aptar Pharma’s Expertise:
With our successful track record of over 900 marketed drug products worldwide, 150 approved NDAs, ANDAs and INDs in the U.S. in the past 5 years alone, and close to 750 patents, you can trust Aptar Pharma with your next drug delivery project. Add to that our status as the global leader in Nasal drug delivery devices for Allergic Rhinitis and in pMDIs for Asthma & COPD, and you can see why we are considered the go-to drug delivery expert. Learn more here.
